Search Results 1031-1040 of 15928 for Residual

1. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

   ... residual disease on postoperative imaging or if there is imaging evidence of disease progression as compared to the first postoperative scan; Measurable or ...

2. Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma - Mayo Clinic

   Patients must have ≤ 1.5 cm2 maximal cross-sectional area of residual tumor (see Section 3.1.4). Whole brain MRI with and without gadolinium and spine MRI ...

3. Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder - Mayo Clinic

   For non-catheterizing subjects, post-void residual is > 100 mL measured by bladder ultrasound, bladder scanner, or one-time catheterization at the time of ...

4. Publications - Laura E. Raffals, M.D. - Mayo Clinic

   Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease. Am J Gastroenterol. 2023 Nov 1; 118 (11):1909 ...

5. Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery - Mayo Clinic

   ... residual disease after surgery are not eligible; A paraffin-embedded surgical tumor tissue specimen has been located is available for shipment to Foundation ...

6. IFX_HU2.0 As An Adjunctive Therapy To Pembrolixumab In Checkpoint Inhibitor Naive Subjects With Advanced Or Metastatic Merkel Cell Carcinoma - Mayo Clinic

   Potential subjects with type I diabetes mellitus, residual hypothyroidism due to autoimmune thyroiditis only requiring hormone replacement, skin disorders ...

7. Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer - Mayo Clinic

   Patients who have not recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities > Common Terminology Criteria for ...

8. A Study of Adding AMG 479 to First Line Chemotherapy in Patients with Optimally Debulked Epithelial Ovarian Cancer - Mayo Clinic

   Must be optimally debulked as defined as having no residual tumor of greater than 1 cm in the post surgical setting. Stage IV disease will be eligible if a ...

9. Neurology - Clinical trials - Mayo Clinic

   [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

10. Treatment of an Inherited Ventricular Arrhythmia - Mayo Clinic

    Confirmed genetic diagnosis of CPVT1 and supporting clinical phenotype, including residual ventricular ectopy (i.e. a complexity score >0) on their last ...